These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 19346103)

  • 1. Dissection of phenotype reveals possible association between schizophrenia and Glutamate Receptor Delta 1 (GRID1) gene promoter.
    Treutlein J; Mühleisen TW; Frank J; Mattheisen M; Herms S; Ludwig KU; Treutlein T; Schmael C; Strohmaier J; Bösshenz KV; Breuer R; Paul T; Witt SH; Schulze TG; Schlösser RG; Nenadic I; Sauer H; Becker T; Maier W; Cichon S; Nöthen MM; Rietschel M
    Schizophr Res; 2009 Jun; 111(1-3):123-30. PubMed ID: 19346103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutamate receptor δ 1 (GRID1) genetic variation and brain structure in schizophrenia.
    Nenadic I; Maitra R; Scherpiet S; Gaser C; Schultz CC; Schachtzabel C; Smesny S; Reichenbach JR; Treutlein J; Mühleisen TW; Deufel T; Cichon S; Rietschel M; Nöthen MM; Sauer H; Schlösser RG
    J Psychiatr Res; 2012 Dec; 46(12):1531-9. PubMed ID: 23017809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association study of polymorphisms in the group III metabotropic glutamate receptor genes, GRM4 and GRM7, with schizophrenia.
    Shibata H; Tani A; Chikuhara T; Kikuta R; Sakai M; Ninomiya H; Tashiro N; Iwata N; Ozaki N; Fukumaki Y
    Psychiatry Res; 2009 May; 167(1-2):88-96. PubMed ID: 19351574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of serotonin transporter promoter gene polymorphism (5-HTTLPR) with depression in Costa Rican schizophrenic patients.
    Contreras J; Hernández S; Quezada P; Dassori A; Walss-Bass C; Escamilla M; Raventos H
    J Neurogenet; 2010 Jul; 24(2):83-9. PubMed ID: 20397838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic variations of human neuropsin gene and psychiatric disorders: polymorphism screening and possible association with bipolar disorder and cognitive functions.
    Izumi A; Iijima Y; Noguchi H; Numakawa T; Okada T; Hori H; Kato T; Tatsumi M; Kosuga A; Kamijima K; Asada T; Arima K; Saitoh O; Shiosaka S; Kunugi H
    Neuropsychopharmacology; 2008 Dec; 33(13):3237-45. PubMed ID: 18354391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-10 gene promoter polymorphism in patients with schizophrenia in a region of East Turkey.
    Ozbey U; Tug E; Namli M
    World J Biol Psychiatry; 2009; 10(4 Pt 2):461-8. PubMed ID: 19153889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms in the promoter region of the alpha1A-adrenoceptor gene are associated with schizophrenia/schizoaffective disorder in a Spanish isolate population.
    Clark DA; Arranz MJ; Mata I; Lopéz-Ilundain J; Pérez-Nievas F; Kerwin RW
    Biol Psychiatry; 2005 Sep; 58(6):435-9. PubMed ID: 16043131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glutamate Networks Implicate Cognitive Impairments in Schizophrenia: Genome-Wide Association Studies of 52 Cognitive Phenotypes.
    Ohi K; Hashimoto R; Ikeda M; Yamamori H; Yasuda Y; Fujimoto M; Umeda-Yano S; Fukunaga M; Fujino H; Watanabe Y; Iwase M; Kazui H; Iwata N; Weinberger DR; Takeda M
    Schizophr Bull; 2015 Jul; 41(4):909-18. PubMed ID: 25537281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resequencing of the vesicular glutamate transporter 2 gene (VGLUT2) reveals some rare genetic variants that may increase the genetic burden in schizophrenia.
    Shen YC; Liao DL; Lu CL; Chen JY; Liou YJ; Chen TT; Chen CH
    Schizophr Res; 2010 Aug; 121(1-3):179-86. PubMed ID: 20541370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tryptophan hydroxylase-1 gene variants associated with schizophrenia.
    Zaboli G; Jönsson EG; Gizatullin R; Asberg M; Leopardi R
    Biol Psychiatry; 2006 Sep; 60(6):563-9. PubMed ID: 16806098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positive associations of polymorphisms in the metabotropic glutamate receptor type 3 gene (GRM3) with schizophrenia.
    Fujii Y; Shibata H; Kikuta R; Makino C; Tani A; Hirata N; Shibata A; Ninomiya H; Tashiro N; Fukumaki Y
    Psychiatr Genet; 2003 Jun; 13(2):71-6. PubMed ID: 12782962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association study of polymorphisms in the excitatory amino acid transporter 2 gene (SLC1A2) with schizophrenia.
    Deng X; Shibata H; Ninomiya H; Tashiro N; Iwata N; Ozaki N; Fukumaki Y
    BMC Psychiatry; 2004 Aug; 4():21. PubMed ID: 15296513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NRG1 and BDNF genes in schizophrenia: an association study in an Italian case-control sample.
    Squassina A; Piccardi P; Del Zompo M; Rossi A; Vita A; Pini S; Mucci A; Galderisi S
    Psychiatry Res; 2010 Mar; 176(1):82-4. PubMed ID: 20061032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association analysis of polymorphisms in the prepronociceptin gene and schizophrenia.
    Imai K; Harada S; Kawanishi Y; Tachikawa H; Okubo T; Suzuki T
    J Hum Genet; 2001; 46(8):442-7. PubMed ID: 11501941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A possible association between schizophrenia and GRIK3 polymorphisms in a multicenter sample of Scandinavian origin (SCOPE).
    Djurovic S; Kähler AK; Kulle B; Jönsson EG; Agartz I; Le Hellard S; Hall H; Jakobsen KD; Hansen T; Melle I; Werge T; Steen VM; Andreassen OA
    Schizophr Res; 2009 Feb; 107(2-3):242-8. PubMed ID: 19022628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The catechol-O-methyl transferase (COMT) gene and its potential association with schizophrenia: findings from a large German case-control and family-based sample.
    Nieratschker V; Frank J; Mühleisen TW; Strohmaier J; Wendland JR; Schumacher J; Treutlein J; Breuer R; Abou Jamra R; Mattheisen M; Herms S; Schmäl C; Maier W; Nöthen MM; Cichon S; Rietschel M; Schulze TG
    Schizophr Res; 2010 Sep; 122(1-3):24-30. PubMed ID: 20643532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [No association of 141C-ins/del polymorphism in the D2 dopamine receptor gene in schizophrenia].
    Rohrmeier T; Putzhammer A; Sartor H; Knapp M; Albus M; Borrmann-Hassenbach M; Lichtermann D; Wildenauer D; Schwab S; Maier W; Klein HE; Eichhammer P
    Psychiatr Prax; 2003 May; 30 Suppl 2():S212-5. PubMed ID: 14509080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for a relationship between genetic variants at the brain-derived neurotrophic factor (BDNF) locus and major depression.
    Schumacher J; Jamra RA; Becker T; Ohlraun S; Klopp N; Binder EB; Schulze TG; Deschner M; Schmäl C; Höfels S; Zobel A; Illig T; Propping P; Holsboer F; Rietschel M; Nöthen MM; Cichon S
    Biol Psychiatry; 2005 Aug; 58(4):307-14. PubMed ID: 16005437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association study of dopamine transporter gene and schizophrenia in Korean population using multiple single nucleotide polymorphism markers.
    Jeong SH; Joo EJ; Ahn YM; Kim YS
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Sep; 28(6):975-83. PubMed ID: 15380858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of variants in the promoter region of PIK3C3 in schizophrenia.
    Tang R; Zhao X; Fang C; Tang W; Huang K; Wang L; Li H; Feng G; Zhu S; Liu H; He L; Shi Y
    Neurosci Lett; 2008 May; 437(1):42-4. PubMed ID: 18420347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.